Electrochemical N-Acetyl-β-D-glucosaminidase Urinalysis - Toward Sensor Chip-Based Diagnostics of Kidney Malfunction
At a Glance
Section titled “At a Glance”| Metadata | Details |
|---|---|
| Publication Date | 2021-09-30 |
| Journal | Biomolecules |
| Authors | Piyanuch Vibulcharoenkitja, Wipa Suginta, Albert Schulte |
| Institutions | Vidyasirimedhi Institute of Science and Technology |
| Citations | 11 |
| Analysis | Full AI Review Included |
Electrochemical BDD Sensors for Kidney Diagnostics: Technical Documentation & Analysis
Section titled “Electrochemical BDD Sensors for Kidney Diagnostics: Technical Documentation & Analysis”Executive Summary
Section titled “Executive Summary”This research validates a robust, high-sensitivity electrochemical assay for N-acetyl-ß-D-glucosaminidase (GlcNAcase), a critical biomarker for renal tubular damage, utilizing Boron-Doped Diamond (BDD) electrodes.
- Material Selection: Boron-Doped Diamond (BDD) was chosen as the working electrode material due to its exceptional resistance to fouling from phenolic oxidation products, ensuring reliable and reproducible measurements in complex biological matrices like urine.
- Detection Methodology: Differential Pulse Voltammetry (DPV) was successfully employed to quantify the anodic oxidation of the released redox label, 4-nitrophenol (4NP), achieving a practical detection limit of 5 µM.
- Clinical Relevance: The assay accurately distinguished between simulated healthy (5 U/L), concerning (20 U/L), and critically high (100 U/L) GlcNAcase concentrations, demonstrating clear diagnostic potential.
- Scalability Demonstrated: Feasibility was confirmed using both standard 3-mm BDD disk electrodes and mass-producible 3.6-mm BDD Screen-Printed Electrodes (BDD-SPEs), laying the groundwork for commercial sensor strip development.
- Performance Advantage: The BDD platform offers a technically undemanding electrochemical urinalysis solution, suitable for adaptation into portable, handheld devices for decentralized clinical and personal health monitoring.
- 6CCVD Value Proposition: 6CCVD specializes in the custom fabrication of high-purity BDD wafers and precision-cut electrodes required to replicate and scale this advanced biosensor technology.
Technical Specifications
Section titled “Technical Specifications”The following hard data points were extracted from the research detailing the electrochemical performance and assay parameters.
| Parameter | Value | Unit | Context |
|---|---|---|---|
| Working Electrode Material | Boron-Doped Diamond (BDD) | N/A | Chosen for anti-fouling properties |
| Standard WE Diameter | 3 | mm | Rod-type BDD disk electrode |
| SPE WE Diameter | 3.6 | mm | Screen-Printed BDD electrode |
| Detection Technique | Differential Pulse Voltammetry (DPV) | N/A | Used for 4NP quantification |
| Practical Detection Limit (4NP) | 5 | µM | Lowest concentration for analyzable DPV peaks |
| Anodic Oxidation Potential (4NP) | +1.05 | V | vs. Ag/AgCl (3 M KCl) Reference Electrode |
| Substrate Concentration | 0.5 | mM | GlcNAc-4NP in assay buffer |
| Buffer pH | 7.0 | N/A | Optimal for GlcNAcase activity |
| Assay Temperature | 25 | °C | Room temperature (simulating home-use conditions) |
| DPV Linearity (R2) | 0.9968 | N/A | 4NP concentration vs. DPV peak current (5-1000 µM) |
| GlcNAcase Concentration Range | 5 to 100 | U/L | Simulated healthy to critical kidney states |
| Incubation Time (Optimal) | 30 | min | Required for clear distinction between GlcNAcase levels |
Key Methodologies
Section titled “Key Methodologies”The following steps outline the critical procedures used to achieve reliable GlcNAcase detection using BDD electrodes:
- Electrochemical Cell Configuration: A standard three-electrode system was utilized, consisting of the BDD disk Working Electrode (WE), a Platinum (Pt) sheet Counter Electrode (CE), and an Ag/AgCl (3 M KCl) Reference Electrode (RE).
- Electrolyte Preparation: The assay was conducted in 0.1 M Phosphate Buffered Saline (PBS) at pH 7.0, supplemented with the redox-labeled substrate, GlcNAc-4NP.
- BDD Surface Regeneration: To maintain consistent performance and mitigate electrode fouling from 4NP oxidation products, the BDD disk surface was rigorously regenerated between trials by polishing with a thick suspension of 0.4 µm alumina powder.
- Enzymatic Reaction: Diluted urine samples were incubated with the GlcNAc-4NP substrate at 25 °C. The GlcNAcase present in the urine catalyzes the release of the redox-active signaling molecule, 4-nitrophenol (4NP).
- Voltammetric Analysis: A portable potentiostat was used to execute Differential Pulse Voltammetry (DPV). The resulting anodic peak current, corresponding to the oxidation of 4NP, was measured and correlated directly to the GlcNAcase concentration in the original urine sample.
- Sensor Scalability Testing: The methodology was successfully transferred from the standard BDD disk WE to commercial, mass-producible BDD Screen-Printed Electrodes (SPEs) to validate the potential for high-volume manufacturing of diagnostic strips.
6CCVD Solutions & Capabilities
Section titled “6CCVD Solutions & Capabilities”The development of robust, high-performance electrochemical biosensors, particularly those requiring the unique properties of diamond, aligns perfectly with 6CCVD’s core expertise. We offer the materials and customization services necessary to transition this research from the laboratory bench to a mass-producible diagnostic platform.
Applicable Materials
Section titled “Applicable Materials”To replicate and scale the GlcNAcase urinalysis assay, researchers require highly uniform, conductive BDD material that minimizes background current and resists fouling.
| 6CCVD Material Recommendation | Specification & Application |
|---|---|
| Boron-Doped Diamond (BDD) Wafers | Essential for the working electrode. Our BDD material provides the necessary wide potential window and chemical inertness to resist fouling from complex urine constituents and phenolic oxidation products. |
| Polycrystalline Diamond (PCD) Substrates | Available in large formats (up to 125 mm diameter) for high-throughput manufacturing of BDD-SPEs, ensuring cost-effective scalability for diagnostic strips. |
| Ultra-Smooth Polishing | We provide polishing services achieving Ra < 5nm on inch-size PCD/BDD, critical for optimizing electron transfer kinetics and ensuring consistent sensor performance, as demonstrated by the paper’s reliance on precise surface regeneration. |
Customization Potential for Sensor Integration
Section titled “Customization Potential for Sensor Integration”The research highlights the need for specific electrode dimensions and the integration of counter and reference electrodes, which are standard offerings at 6CCVD.
| Required Customization | 6CCVD Capability |
|---|---|
| Custom Electrode Dimensions | We provide precision laser cutting and dicing services to produce BDD disks at exact specifications (e.g., 3 mm or 3.6 mm diameter) for both rod-type electrodes and SPE integration. |
| Integrated Metalization | The paper used external Pt and Ag/AgCl electrodes. 6CCVD offers in-house metalization (Au, Pt, Pd, Ti, W, Cu) directly onto BDD substrates, enabling the creation of fully integrated, single-chip BDD-SPEs with built-in counter and reference electrodes. |
| Thickness Control | We offer precise control over BDD film thickness (0.1 µm to 500 µm) and substrate thickness (up to 10 mm), allowing optimization for both laboratory prototypes and thin-film SPE manufacturing. |
Engineering Support
Section titled “Engineering Support”6CCVD’s in-house PhD team provides specialized consultation to accelerate development in advanced electrochemical applications.
- Material Optimization: Our experts can assist with optimizing BDD doping levels and surface termination to maximize 4NP sensitivity and further minimize background currents in complex biological media.
- Fouling Mitigation: We offer consultation on BDD surface chemistry and cleaning protocols, building upon the paper’s successful use of alumina polishing, to develop robust, long-life sensors for GlcNAcase urinalysis projects.
- Global Logistics: We ensure reliable, global shipping (DDU default, DDP available) of sensitive diamond materials, supporting international research and manufacturing supply chains.
For custom specifications or material consultation, visit 6ccvd.com or contact our engineering team directly.
View Original Abstract
N-Acetyl-β-D-glucosaminidase (GlcNAcase) is a valuable biomarker for kidney health, as an increased urinary level of the enzyme indicates cell damage within the renal tubular filtration system from acute or chronic organ injury or exposure to nephrotoxic compounds. Effective renal function is vital for physiological homeostasis, and early detection of acute or chronic renal malfunction is critically important for timely treatment decisions. Here, we introduce a novel option for electrochemical urinalysis of GlcNAcase, based on anodic differential pulse voltammetry at boron-doped diamond disk sensors of the oxidizable product 4-nitrophenol (4NP), which is released by the action of GlcNAcase on the synthetic substrate 4NP-N-acetyl-β-D-glucosaminide (GlcNAc-4NP), added to the test solution as a reporter molecule. The proposed voltammetric enzyme activity screen accurately distinguishes urine samples of normal, slightly elevated and critically high urinary GlcNAcase content without interference from other urinary constituents. Moreover, this practice has the potential to be adapted for use in a hand-held device for application in clinical laboratories by physicians or in personal home health care. Evidence is also presented for the effective management of the procedure with mass-producible screen-printed sensor chip platforms.
Tech Support
Section titled “Tech Support”Original Source
Section titled “Original Source”References
Section titled “References”- 1998 - Anatomy and physiology of the kidney [Crossref]
- 2020 - Acute kidney injury [Crossref]
- 2021 - Kidney physiology and susceptibility to acute kidney injury: Implications for renoprotection [Crossref]
- 2020 - Chronic kidney disease [Crossref]
- 2021 - Acute kidney disease to chronic kidney disease [Crossref]
- 1988 - Creatinine as a marker of glomerular filtration rate
- 2001 - Creatinine clearance and the assessment of renal function [Crossref]
- 2019 - Assessment of kidney function in adults [Crossref]
- 2007 - Biomarkers of acute kidney injury: Can we replace serum creatinine? [Crossref]
- 2009 - Creatinine as the gold standard for kidney injury biomarker studies? [Crossref]